Literature DB >> 8022775

Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene.

J S Khillan1, S W Li, D J Prockop.   

Abstract

Previously, transgenic mice were prepared that developed a lethal phenotype of fragile bones because they expressed an internally deleted mini-gene for the pro alpha 1(I) chain of human type I procollagen. The shortened pro alpha 1(I) chains synthesized from the human transgene bound to and produced degradation of normal pro alpha 1(I) chains synthesized from the normal mouse alleles. Here we assembled an antisense gene that was similar to the internally deleted COL1A1 minigene but the 3' half of the gene was inverted so as to code for an antisense RNA. Transgenic mice expressing the antisense gene had a normal phenotype, apparently because the antisense gene contained human sequences instead of mouse sequences. Two lines of mice expressing the antisense gene were bred to two lines of transgenic mice expressing the mini-gene. In mice that inherited both genes, the incidence of the lethal fragile bone phenotype was reduced from 92% to 27%. The effects of the antisense gene were directly demonstrated by an increase in the ratio of normal mouse pro alpha 1(I) chains to human mini-pro alpha 1(I) chains in tissues from mice that inherited both genes and had a normal phenotype. The results raise the possibility that chimeric gene constructs that contain intron sequences and in which only the second half of a gene is inverted may be particularly effective as antisense genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022775      PMCID: PMC44188          DOI: 10.1073/pnas.91.14.6298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  High levels of expression of a minigene version of the human pro alpha 1 (I) collagen gene in stably transfected mouse fibroblasts. Effects of deleting putative regulatory sequences in the first intron.

Authors:  A S Olsen; A E Geddis; D J Prockop
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

2.  Production of phenocopies by Krüppel antisense RNA injection into Drosophila embryos.

Authors:  U B Rosenberg; A Preiss; E Seifert; H Jäckle; D C Knipple
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

3.  Complete nucleotide sequence of the region encompassing the first twenty-five exons of the human pro alpha 1(I) collagen gene (COL1A1)

Authors:  M D'Alessio; M Bernard; P J Pretorius; W de Wet; F Ramirez; P J Pretorious
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

4.  The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells.

Authors:  Y Saijo; L Perlaky; B C Valdez; R K Busch; D Henning; W W Zhang; H Busch
Journal:  Cancer Lett       Date:  1993-02       Impact factor: 8.679

5.  A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA).

Authors:  T Mizuno; M Y Chou; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Anti-mRNA: specific inhibition of translation of single mRNA molecules.

Authors:  S Pestka; B L Daugherty; V Jung; K Hotta; R K Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Reduction of polygalacturonase activity in tomato fruit by antisense RNA.

Authors:  R E Sheehy; M Kramer; W R Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Phenotypic conversion of SV40-immortalized human diploid fibroblasts to senescing cells by introduction of an antisense gene for SV40-T antigen.

Authors:  Y Tanaka; X Tang; D X Hou; H Gao; I Kitabayashi; G Gachelin; K Yokoyama
Journal:  Cell Struct Funct       Date:  1992-12       Impact factor: 2.212

9.  Tissue- and development-specific expression in transgenic mice of a type I procollagen (COL1A1) minigene construct with 2.3 kb of the promoter region and 2 kb of the 3'-flanking region. Specificity is independent of the putative regulatory sequences in the first intron.

Authors:  B P Sokolov; P K Mays; J S Khillan; D J Prockop
Journal:  Biochemistry       Date:  1993-09-07       Impact factor: 3.162

10.  Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice.

Authors:  M Katsuki; M Sato; M Kimura; M Yokoyama; K Kobayashi; T Nomura
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

View more
  5 in total

Review 1.  Antisense and ribozyme constructs in transgenic animals.

Authors:  D L Sokol; J D Murray
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

Review 2.  Gene therapy for inherited retinal degeneration.

Authors:  R R Ali; M B Reichel; D M Hunt; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

Review 3.  Tissue specific and vitamin D responsive gene expression in bone.

Authors:  C White; E Gardiner; J Eisman
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

Review 4.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

5.  Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.

Authors:  R M Porter; S Leitgeb; D W Melton; O Swensson; R A Eady; T M Magin
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.